Cencora, Inc.
Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%
Peer Benchmark: Option Care Health, Inc. (OPCH) của Cencora theo quý
Peer Benchmark: Option Care Health, Inc. (OPCH) — Consolidated Revenue ($M) ($M)
Peer Benchmark: Option Care Health, Inc. (OPCH) của Cencora: $1,442M trong Q3 FY26, tăng 1.9% so với cùng kỳ năm trước. Đó là mức cao nhất trong 52 quý có ở đây.
Số của Q3 FY26 lấy từ đâu
“OPCH us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax = $1,442,400,000 (2026-04-01 to 2026-06-30)”
Nguồn: SEC EDGAR XBRL CompanyFacts (OPCH) ↗
SEC XBRL quarterly and annual benchmark for alternate-site / infusion services peer Option Care Health, Inc. (CIK 0001014739, aligned to Cencora's fiscal calendar).
Lịch sử theo quý
Rê chuột vào một số để xem câu chữ đã đọc ra số đó; số tự tính sẽ hiện công thức
| Kỳ | Kết thúc | Peer Benchmark: Option Care Health, Inc. (OPCH) — Consolidated Revenue ($M) ($M) | So với cùng kỳ | Nguồn |
|---|---|---|---|---|
| Q3 FY26CQ2 2026 | Jun 30, 2026 | 1,442 | +1.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY26CQ1 2026 | Mar 31, 2026 | 1,351 | +1.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY25CQ3 2025 | Sep 30, 2025 | 1,435 | +12.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY25CQ2 2025 | Jun 30, 2025 | 1,416 | +15.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY25CQ1 2025 | Mar 31, 2025 | 1,333 | +16.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY24CQ3 2024 | Sep 30, 2024 | 1,279 | +17.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY24CQ2 2024 | Jun 30, 2024 | 1,227 | +14.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY24CQ1 2024 | Mar 31, 2024 | 1,146 | +12.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 1,093 | +7.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY23CQ2 2023 | Jun 30, 2023 | 1,069 | +9.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY23CQ1 2023 | Mar 31, 2023 | 1,016 | +10.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY22CQ3 2022 | Sep 30, 2022 | 1,021 | +14.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY22CQ2 2022 | Jun 30, 2022 | 981 | +14.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY22CQ1 2022 | Mar 31, 2022 | 916 | +20.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY21CQ3 2021 | Sep 30, 2021 | 892 | +14.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY21CQ2 2021 | Jun 30, 2021 | 860 | +16.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY21CQ1 2021 | Mar 31, 2021 | 759 | +7.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY21CQ4 2020 | Dec 31, 2020 | 805 | +11.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY20CQ3 2020 | Sep 30, 2020 | 782 | +26.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY20CQ2 2020 | Jun 30, 2020 | 741 | +49.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY20CQ1 2020 | Mar 31, 2020 | 705 | +48.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY20CQ4 2019 | Dec 31, 2019 | 721 | +42.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY19CQ3 2019 | Sep 30, 2019 | 616 | +24.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY19CQ2 2019 | Jun 30, 2019 | 497 | +3.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY19CQ1 2019 | Mar 31, 2019 | 477 | +3.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY19CQ4 2018 | Dec 31, 2018 | 506 | +176.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY18CQ3 2018 | Sep 30, 2018 | 494 | +148.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY18CQ2 2018 | Jun 30, 2018 | 480 | +119.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY18CQ1 2018 | Mar 31, 2018 | 461 | +111.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY18CQ4 2017 | Dec 31, 2017 | 183 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY17CQ3 2017 | Sep 30, 2017 | 199 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY17CQ2 2017 | Jun 30, 2017 | 218 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY17CQ1 2017 | Mar 31, 2017 | 218 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY14CQ3 2014 | Sep 30, 2014 | 244 | +28.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY14CQ2 2014 | Jun 30, 2014 | 247 | +43.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY14CQ1 2014 | Mar 31, 2014 | 239 | +32.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY13CQ3 2013 | Sep 30, 2013 | 191 | +11.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY13CQ2 2013 | Jun 30, 2013 | 172 | +10.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY13CQ1 2013 | Mar 31, 2013 | 181 | +16.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY12CQ3 2012 | Sep 30, 2012 | 170 | +27.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY12CQ2 2012 | Jun 30, 2012 | 156 | +18.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY12CQ1 2012 | Mar 31, 2012 | 156 | +19.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY11CQ3 2011 | Sep 30, 2011 | 134 | -69.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY11CQ2 2011 | Jun 30, 2011 | 132 | -68.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY11CQ1 2011 | Mar 31, 2011 | 131 | -61.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY10CQ3 2010 | Sep 30, 2010 | 441 | +32.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY10CQ2 2010 | Jun 30, 2010 | 412 | +25.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY10CQ1 2010 | Mar 31, 2010 | 335 | +2.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY09CQ3 2009 | Sep 30, 2009 | 334 | -7.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY09CQ2 2009 | Jun 30, 2009 | 329 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY09CQ1 2009 | Mar 31, 2009 | 326 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY08CQ3 2008 | Sep 30, 2008 | 359 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
Phân tách
peer Benchmark: Option Care Health, Inc. (OPCH) gồm những gì
Trích dẫn dữ liệu này
StockData. (2026). Peer Benchmark: Option Care Health, Inc. (OPCH) ($M) của Cencora, theo quý Q4 FY08–Q3 FY26 [Bộ dữ liệu]. Tổng hợp từ Hồ sơ SEC và tài liệu dành cho nhà đầu tư của Cencora. https://stockdatahq.com/stocks/cor/kpis/peer-opch-rev
Xem mọi chỉ số ở bảng KPI của Cencora. Dữ liệu cập nhật Nov 7, 2026.
See a number that looks wrong?